Moleculin Biotech, Inc. - 10-Q Filing
Moleculin Biotech reports Q3 2026 results with 1,061,533 shares outstanding as of November 6, 2026
Tickers: $MBRX
Read the full article at SEC EDGAR
Part of the story PharmaCyte Biotech, Inc. - 8-K Filing (2 articles)